Given that the pancreatic cancer cell lines applied in the current study both harboured KRAS mutation, the most frequent genetic mutation observed in pancreatic cancer, we were interested in investigating if EPLIN is involved in the KRAS networks. The gene discussed is KRAS; the disease is pancreatic neoplasm.